Skip to main content

Table 4 Concordance indices of the current three-strata risk group model (NICE) and Cambridge Prognostic Group (CPG) from competing risk analysis in predicting prostate cancer-specific mortality (p < 0.001 for both comparisons)

From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

 

Concordance index (confidence interval)

Cohort (n)

NICE

CPG

PCBaSe (72,337)

0.77 (0.76–0.77)

0.81 (0.81–0.82)

Singapore (2550)

0.76 (0.73–0.80)

0.79 (0.76–0.83)